http://orcid.org/0000-0001-5735-9530
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
"Baclofen and the “first do not harm” motto: a new French paradox?." Clinical Toxicology, 56(4), pp. 307–308
Disclosure statement
AB was a late co-investigator for NCT01738282 trial (baclofen) but did not recruit. He is an expert for several taskforces at the French drug agency (Agence Nationale de Sécurité du Médicament, ANSM), none related to alcohol use disorders treatment.
FN had travel/accommodations expenses covered by Servier, BMS, Lundbeck and Janssen. He was invited by Lundbeck for an oral communication at a symposium on the neurobiology of alcohol dependence in 2014 and explicitly refused payment.